MedClub® We utilize the research & written protocols of the Front Line Covid-19 Critical Care Alliance. Private Tele-Medicine or Clinic Visits.
Updates:
These are certainly novel times in medicine, we have seen healthcare agencies make claims that turned out to be ineffective or false, which has led to a division among healthcare providers and the scientific community. What is even more strange is that when these agencies make a claim based on limited research, they unintentionally move the goal post when it comes to what direction to point providers and patients. Everyone seems to be playing a game of kick the can, but we fear it might be more like a game of telephone. One research team creates a report including hundreds of pages of data, then it is passed to someone who works for a large healthcare agency and it is made into a one paragraph digestible bite size clip that can be made into a public statement for the press. The problem is not only with the amount of information being left out, but also the time in which the information is gathered. Issues surrounding covid-19, spike proteins, long haul syndromes, and mutations cannot be summarized in a footnote. They need to be peer reviewed, and subjected to the scientific method with as little bias as possible. This process takes time, there is no substitute for time. If this cannot be achieved, the only statement that should be put out is that the scientific community is working on it, and further analysis is needed. People should feel confident when asking their physicians for help, and the physicians should feel confident that in a situation when standardized protocols do not exist, they can abide by the hypocritical oath to do no harm, and treat patients to the best of their ability with the tools they have currently. Penalizing providers for trying to treat a diseases symptoms when none of the "allowed" treatments have been effective, or subjected to the scientific method is simply a disservice to the people suffering.
Prevention
The first step is ensuring your immune system has the right mix of vitamins and minerals to perform its basic functions at the highest possible level. Covid-19 has shown us that people with compromised immunity are at significant risk for contracting a more serious illness, as well as experiencing a more serious level of symptoms.
If you are not in high risk situations you can easily follow the vitamin protocol below, all of the vitamins are available commercially. You can use this link to setup a Fullscript® account and view Dr. Jenns Covid-19 Vitamin Protocol. All patients who use this link get an automatic 15% off retail, along with standardized testing of each supplement on the list so you can be sure the dosages are exact, with no harmful ingredients.
The next step in prevention is for people who are in high risk scenarios, or will be going into situations where the risk for exposure is high. This can include traveling, seeing family who have been exposed, work related exposure etc..
Ivermectin and other similar anti-vital medications have been shown to be very effective at lowering the viral load of the covid-19 virus, and have a long track record of being very safe drugs. We have been using anti-virals such as Ivermectin with good success in our practice and have developed some of our protocols around it. It is a weight based medication so it is very important that this medication only be taken by the prescribed patient. High dose vitamin C IV infusions have also been shown to be effective at raising the immunity of individuals especially prophylactically, this can be done 24-48 hours before traveling, visiting with family, work events etc...
Outpatient Treatment of Covid-19
Treatment of Covid-19, symptoms of "Long-Covid" or the treatment of the spike proteins that develop as a result from previous exposure to either the virus itself or the immunization of Sars-Cov-2. Treatment regiments have been slowly developed combining commercially available generic antivirals with high concentration vitamin infusions, vitamin protocols, and now even monoclonal antibodies. The truth is we can only treat this virus and its mutations using the tools we have, but as time passes health care workers have been able to experiment with larger and larger numbers of patients. When we have a good result we share it with other health care professionals all over the world so that they can implement new techniques in their respective countries. This being said, the research and protocols we use are actively being updated, so this article will be updated weekly as new treatment information becomes available to us.
Our outpatient treatment plan is not the same for everyone but includes the same basic principals of treatment:
Vitamin/Supplement Protocol in tested specific amounts and frequencies. (Must register for FullScript account to get our clinic discount of -15% MSRP)
Antiviral Medication - Ivermectin most commonly used, safe, effective at lowering viral load, millions of doses used, prescribed by weight, used in off label dosages.
Antibiotics - Only used prophylactically in certain cases to prevent high risk patients from co-occuring bacterial infections.
Vitamin-C (Myers) IV Infusion - IV Infusion containing 15-30 grams of Vitamin C intravenous solution typically administered every 3-4 days until recovered.
Monoclonal Antibody Treatment - Monoclonal antibodies for COVID-19 may block the virus that causes COVID-19 from attaching to human cells, making it more difficult for the virus to reproduce & cause harm. Monoclonal antibodies may also neutralize a virus. There are 3 variations available in the US: Bamlanivimab plus etesevimab, Casirivimab plus imdevimab, & Sotrovimab.
The COVID-19 Treatment Guidelines Panel (the Panel) recommends using one of the following anti-SARS-CoV-2 monoclonal antibodies, listed in alphabetical order, to treat nonhospitalized patients with mild to moderate COVID-19 who are at high risk of clinical progression (see below for criteria and discussion):
Casirivimab plus imdevimab; or
Sotrovimab 500 mg intravenous (IV) infusion
When using casirivimab plus imdevimab, the Panel recommends:
Casirivimab 600 mg plus imdevimab 600 mg IV infusion (AIIa)
If IV infusions are not feasible or would cause a delay in treatment, casirivimab 600 mg plus imdevimab 600 mg administered by four subcutaneous (SQ) injections (2.5 mL per injection) can be used as an alternative (BIII).
At this time, the Panel recommends against the use of bamlanivimab plus etesevimab (AIII) because the Gamma (P.1) and Beta (B.1.351) VoC, which have reduced susceptibility to both agents, are circulating in the United States.
Credit NIH
Long Haul Covid Syndrome
LHCS is an often debilitating syndrome characterized by a multitude of symptoms such as prolonged malaise, headaches, generalized fatigue, sleep difficulties, smell disorder, decreased appetite, painful joints, dyspnea, chest pain and cognitive dysfunction. The incidence of symptoms after COVID-19 varies from as low as 10% to as high as 80%. LHCS is not only seen after the COVID-19 infection but it is being observed in some people that have received vaccines (likely due to monocyte activation by the spike protein from the vaccine). A puzzling feature of the LHCS syndrome is that it is not predicted by initial disease severity; post-COVID-19 frequently affects mild-to-moderate cases and younger adults that did not require respiratory support or intensive care.
If you are experience mild to moderate symptoms of Covid-19 or will be traveling to a high risk situation/environment please reach out to our office to setup a Tele-Medicine Consultation with our physician.
The cost for the consultation and basic treatment/prevention plan is $225 plus applicable medication costs from the pharmacy. No Insurance is accepted.
If you would like to use your insurance for Covid-19 Outpatient Care please contact your Primary care Physician or Insurance Provider for a directory of providers in your network.
If you would like to fill out our new patient intake form our staff will reach out to you when they receive it. It will require an uploaded drivers license or ID card, only US residents living in the continental United States are permitted to be treated via Tele-Medicine. You can use the link below to fill out the form.
MedClub®
561-214-3323
Source Material: FLCCC/NPBI/NIH